Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Free access | 10.1172/JCI109226

Human Antihapten Antibodies in Trimellitic Anhydride Inhalation Reactions: IMMUNOGLOBULIN CLASSES OF ANTI-TRIMELLITIC ANHYDRIDE ANTIBODIES AND HAPTEN INHIBITION STUDIES

Roy Patterson, C. Raymond Zeiss, Mary Roberts, Jacob J. Pruzansky, Peter Wolkonsky, and R. Chacon

Section of Allergy-Immunology, Department of Medicine, Northwestern University Medical School, and Standard Oil Company (Indiana), Chicago, Illinois 60611

Find articles by Patterson, R. in: PubMed | Google Scholar

Section of Allergy-Immunology, Department of Medicine, Northwestern University Medical School, and Standard Oil Company (Indiana), Chicago, Illinois 60611

Find articles by Zeiss, C. in: PubMed | Google Scholar

Section of Allergy-Immunology, Department of Medicine, Northwestern University Medical School, and Standard Oil Company (Indiana), Chicago, Illinois 60611

Find articles by Roberts, M. in: PubMed | Google Scholar

Section of Allergy-Immunology, Department of Medicine, Northwestern University Medical School, and Standard Oil Company (Indiana), Chicago, Illinois 60611

Find articles by Pruzansky, J. in: PubMed | Google Scholar

Section of Allergy-Immunology, Department of Medicine, Northwestern University Medical School, and Standard Oil Company (Indiana), Chicago, Illinois 60611

Find articles by Wolkonsky, P. in: PubMed | Google Scholar

Section of Allergy-Immunology, Department of Medicine, Northwestern University Medical School, and Standard Oil Company (Indiana), Chicago, Illinois 60611

Find articles by Chacon, R. in: PubMed | Google Scholar

Published November 1, 1978 - More info

Published in Volume 62, Issue 5 on November 1, 1978
J Clin Invest. 1978;62(5):971–978. https://doi.org/10.1172/JCI109226.
© 1978 The American Society for Clinical Investigation
Published November 1, 1978 - Version history
View PDF
Abstract

Inhalational exposure to trimellitic anhydride (TMA) produces an immediate-type asthmatic or a late respiratory systemic syndrome in certain workers after a latent period of work exposure. TMA has been found to react with proteins to produce a hapten-protein complex (trimellitate [TM] protein) or become hydrolyzed in aqueous, alkaline solutions to produce a salt, NaTM. Using a solid-phase radioimmunoassay technique, antibodies of different Ig classes were detected against TM-protein conjugates. IgE antibody was detected in three of five workers with asthma. IgG and IgA antibodies were detected in most exposed workers but higher levels of antibody were found in symptomatic workers even after long periods without direct TMA exposure. IgM antibody activity against TM-human serum albumin (TM-HSA) was detected but did not differentiate symptomatic from asymptomatic workers. NaTM served as a hapten for study because it does not react with proteins to form a hapten-protein complex as TMA does. The NaTM only partially inhibited IgG antibody activity against TM-HSA and much smaller amounts of TM-HSA than of NaTM were required to neutralize IgG antibody. A similar result was found with TM-ovalbumin. The latter results suggest that some IgG antibody is directed against a TM-protein moiety, probably a TM-amino acid determinant. In contrast to IgG, marked inhibition by NaTM of IgA and IgM antibody against TM-HSA was found in the sera studied.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 971
page 971
icon of scanned page 972
page 972
icon of scanned page 973
page 973
icon of scanned page 974
page 974
icon of scanned page 975
page 975
icon of scanned page 976
page 976
icon of scanned page 977
page 977
icon of scanned page 978
page 978
Version history
  • Version 1 (November 1, 1978): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts